These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21695705)

  • 1. ["Demarcation issues" - an unusual subject in Pharmazie in unserer Zeit? Not at all!].
    Knöss W; Dingermann T
    Pharm Unserer Zeit; 2011 Jul; 40(4):293. PubMed ID: 21695705
    [No Abstract]   [Full Text] [Related]  

  • 2. [Europeanisation of law. Demarcation issues in court].
    Schemmer F
    Pharm Unserer Zeit; 2011 Jul; 40(4):345-50. PubMed ID: 21698634
    [No Abstract]   [Full Text] [Related]  

  • 3. [What rules apply here and who is responsible? How drugs are distinguished from other health care products?].
    Stephan K
    Pharm Unserer Zeit; 2011 Jul; 40(4):300-4. PubMed ID: 21698627
    [No Abstract]   [Full Text] [Related]  

  • 4. [A consideration from the scientific perspective. Health products: which is food, which is medicine?].
    Hahn A
    Pharm Unserer Zeit; 2011 Jul; 40(4):306-15. PubMed ID: 21698629
    [No Abstract]   [Full Text] [Related]  

  • 5. [Editorial: Pharmazie in unserer Zeit 4/2012].
    Dingermann T; Schubert-Zsilavecz M; Schulz M
    Pharm Unserer Zeit; 2012 Jul; 41(4):267. PubMed ID: 22753113
    [No Abstract]   [Full Text] [Related]  

  • 6. [A question of distribution options. Demarcation of plant products].
    Schraitle R
    Pharm Unserer Zeit; 2011 Jul; 40(4):326-30. PubMed ID: 21698631
    [No Abstract]   [Full Text] [Related]  

  • 7. Biosimilar medicines--new challenges for a new class of medicine.
    Fox A
    J Biopharm Stat; 2010 Jan; 20(1):3-9. PubMed ID: 20077245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological properties as criterion of demarcation].
    Stephan K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Mar; 60(3):286-291. PubMed ID: 28054116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmazie in unserer Zeit 3/2009].
    Link A; Schubert-Zsilavecz M
    Pharm Unserer Zeit; 2009; 38(3):201. PubMed ID: 19396902
    [No Abstract]   [Full Text] [Related]  

  • 10. [Naming and packaging of pharmaceutical products].
    Bruhn C
    Dtsch Med Wochenschr; 2013 Nov; 138(46):2340-1. PubMed ID: 24350365
    [No Abstract]   [Full Text] [Related]  

  • 11. [Toxicological evaluation and delineation. Food - nutritional supplements - pharmaceuticals].
    Schrenk D
    Pharm Unserer Zeit; 2011 Jul; 40(4):316-24. PubMed ID: 21698630
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmazie in unserer Zeit 1/2009].
    Schoettler P; Dingermann T; Schubert-Zsilavecz M
    Pharm Unserer Zeit; 2009; 38(1):3. PubMed ID: 19132674
    [No Abstract]   [Full Text] [Related]  

  • 13. [Editorial: Pharmazie in unserer Zeit 2/2010].
    Blume H; Schubert-Zsilavecz M
    Pharm Unserer Zeit; 2010 Mar; 39(2):91. PubMed ID: 20196058
    [No Abstract]   [Full Text] [Related]  

  • 14. Misleading data in pharmaceutical and biological patent specifications: best mode after the America Invents Act.
    Laporte C; Deneke CC; Banks D
    Pharm Pat Anal; 2015; 4(4):247-51. PubMed ID: 26174564
    [No Abstract]   [Full Text] [Related]  

  • 15. The regulation of drugs and biologics: fifty years into the future.
    Kuhlik BN
    Food Drug Law J; 2000; 55(1):21-5. PubMed ID: 12269358
    [No Abstract]   [Full Text] [Related]  

  • 16. [Editorial: Pharmazie in unserer Zeit 1/2011].
    Dingermann T; Zeuzem S
    Pharm Unserer Zeit; 2011 Jan; 40(1):3. PubMed ID: 21194071
    [No Abstract]   [Full Text] [Related]  

  • 17. [Demarcation problem. Clinical trials of dietary supplements].
    Steffen C
    Pharm Unserer Zeit; 2011 Jul; 40(4):332-7. PubMed ID: 21698632
    [No Abstract]   [Full Text] [Related]  

  • 18. [Editorial: Pharmazie in unserer Zeit 6/2012].
    Dingermann T
    Pharm Unserer Zeit; 2012 Nov; 41(6):439. PubMed ID: 23124574
    [No Abstract]   [Full Text] [Related]  

  • 19. Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system.
    Lindenberg M; Kopp S; Dressman JB
    Eur J Pharm Biopharm; 2004 Sep; 58(2):265-78. PubMed ID: 15296954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From pharmaceuticals to nutraceuticals: bridging disease prevention and management.
    Daliu P; Santini A; Novellino E
    Expert Rev Clin Pharmacol; 2019 Jan; 12(1):1-7. PubMed ID: 30484336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.